Supernus to Participate in Upcoming September Investor Conferences
Get Alerts SUPN Hot Sheet
Join SI Premium – FREE
ROCKVILLE, Md., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the Company’s management will participate and host investor meetings in the following upcoming September 2021 virtual investor conferences.
Citi’s 16th Annual BioPharma Virtual ConferenceDate: Thursday, September 9, 2021Participation Type: One-on-one meetings
Wells Fargo 2021 Virtual Healthcare ConferenceDate: Friday, September 10, 2021Participation Type: PresentationPresentation Time: 9:20 a.m. ET
Morgan Stanley 19th Annual Global Healthcare ConferenceDate: Wednesday, September 15, 2021Participation Type: Fireside ChatPresentation Time: 11:45 a.m. ET
A live webcast of the events can be accessed by visiting Events & Presentations in the Investor Relations section on the Company's website at www.supernus.com. An archived replay of each webcast will be available for 60 days on the Company's website after the respective conference.
About Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases.
Our diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, ADHD, hypomobility in Parkinson’s disease, cervical dystonia and chronic sialorrhea. We are developing a broad range of novel CNS product candidates including new potential treatments for hypomobility in Parkinson’s disease, epilepsy, depression and rare CNS disorders.
For more information, please visit www.supernus.com.
CONTACTS:
Jack A. Khattar, President and Chief Executive Officer Supernus Pharmaceuticals, Inc.Tel: (301) 838-2591
or
INVESTOR CONTACT:Peter VozzoWestwicke/ICROffice: (443) 213-0505Mobile: (443) 377-4767Email: [email protected]
Source: Supernus Pharmaceuticals, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SOUEAST C-DM Hybrid System: Adapting to Urban and Intercity Travel Needs
- From Whitelist to the Next Meme Wave: Apeing Eyes the Best Meme Coin Spot While Snek and Pepe Hold Their Ground
- Solana Unchained Emerges as a Closely Watched Solana Presale Following Product Ecosystem Reveal
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Citi, Morgan Stanley, Wells FargoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share